Overview

Neoadjuvant Chemo for Non-metastatic Non-small Cell Lung Cancer

Status:
Terminated
Trial end date:
2016-04-01
Target enrollment:
Participant gender:
Summary
To determine the rate of pathologic complete responses (pCR) at the time of definitive surgical resection of non-small cell lung cancer (NSCLC)
Phase:
Phase 2
Details
Lead Sponsor:
Western Regional Medical Center
Treatments:
Cisplatin
Gemcitabine
Pemetrexed